Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D
- PMID: 12485959
- DOI: 10.1124/dmd.31.1.108
Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D
Abstract
7-Ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of antitumor agent irinotecan (CPT-11), is conjugated and detoxified to SN-38-glucuronide by UDP-glucuronosyltransferase (UGT) 1A1. Genetic polymorphisms in UGT1A1 are thought to contribute to severe diarrhea and/or leukopenia caused by CPT-11. In this regard, it has been reported that polymorphisms in the promoter region could affect the CPT-11 pharmacokinetics and interindividual variation of toxicity. However, little information is available on the influence of UGT1A1 polymorphisms in the coding region on the SN-38 glucuronidation activity. In the present study, wild-type (WT) and three variant (G71R, P229Q, and Y486D) cDNAs of human UGT1A1s were transiently expressed in COS-1 cells, and the kinetic parameters of these UGT1A1s were determined for SN-38 glucuronidation. A partially reduced UGT1A1 protein expression was observed in COS-1 cells for G71R and Y486D. WT UGT1A1 catalyzed SN-38 glucuronidation with an apparent K(m) value of 11.5 microM, whereas those of G71R, P229Q, and Y486D were 14.0, 18.0, and 63.5 microM, respectively. The SN-38 glucuronidation efficiency ratio (V(max)/K(m)) normalized for the level of expression was 1.4, 0.66 (47% of WT), 0.73 (52%), and 0.07 (5%) microl/min/mg of protein for WT, G71R, P229Q, and Y486D, respectively. Thus, the SN-38 glucuronidation activity of Y486D was drastically reduced, whereas the reduction in the G71R and P229Q activities was fractional. The decreased SN-38 glucuronidation efficiency ratio of G71R and P229Q could be critical in combination with other polymorphisms in the UGT1A1 gene.
Similar articles
-
Pharmacogenetics of irinotecan disposition and toxicity: a review.Curr Clin Pharmacol. 2010 Aug;5(3):209-17. doi: 10.2174/157488410791498806. Curr Clin Pharmacol. 2010. PMID: 20406168 Review.
-
Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C> T (P229L) found in an African-American.Drug Metab Dispos. 2005 Mar;33(3):458-65. doi: 10.1124/dmd.104.001800. Epub 2004 Nov 30. Drug Metab Dispos. 2005. PMID: 15572581
-
Irinotecan treatment in cancer patients with UGT1A1 polymorphisms.Oncology (Williston Park). 2003 May;17(5 Suppl 5):52-5. Oncology (Williston Park). 2003. PMID: 12800608 Review.
-
Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients.J Pharmacol Exp Ther. 2003 Aug;306(2):688-93. doi: 10.1124/jpet.103.051250. Epub 2003 May 1. J Pharmacol Exp Ther. 2003. PMID: 12730278
-
Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.Xenobiotica. 2001 Oct;31(10):687-99. doi: 10.1080/00498250110057341. Xenobiotica. 2001. PMID: 11695848
Cited by
-
[UGT1A1 gene mutations in Chinese Dong neonates in Sanjiang, Guangxi].Zhongguo Dang Dai Er Ke Za Zhi. 2022 Jul 15;24(7):792-796. doi: 10.7499/j.issn.1008-8830.2202127. Zhongguo Dang Dai Er Ke Za Zhi. 2022. PMID: 35894195 Free PMC article. Chinese.
-
Decreased Tissue Omega-6/Omega-3 Fatty Acid Ratio Prevents Chemotherapy-Induced Gastrointestinal Toxicity Associated with Alterations of Gut Microbiome.Int J Mol Sci. 2022 May 10;23(10):5332. doi: 10.3390/ijms23105332. Int J Mol Sci. 2022. PMID: 35628140 Free PMC article.
-
Effect of the genetic mutant G71R in uridine diphosphate-glucuronosyltransferase 1A1 on the conjugation of bilirubin.Open Life Sci. 2022 Mar 18;17(1):221-229. doi: 10.1515/biol-2022-0021. eCollection 2022. Open Life Sci. 2022. PMID: 35415244 Free PMC article.
-
Quantitative Investigation of Irinotecan Metabolism, Transport, and Gut Microbiome Activation.Drug Metab Dispos. 2021 Aug;49(8):683-693. doi: 10.1124/dmd.121.000476. Epub 2021 Jun 1. Drug Metab Dispos. 2021. PMID: 34074730 Free PMC article.
-
Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen.Pharmgenomics Pers Med. 2021 Mar 23;14:369-377. doi: 10.2147/PGPM.S292556. eCollection 2021. Pharmgenomics Pers Med. 2021. PMID: 33790625 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources